Interleukin-6 (IL-6) was found to cause multidrug resistance in breast cancer cells by activating the CCAAT enhancer-binding protein family of transcription factors and inducing mdr1 gene expression [6]. The gene discussed is IL6; the disease is breast carcinoma.